Bristol-Myers Squibb Co vs Cloudflare Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.65 (market cap $129.94B), while Cloudflare Inc trades at $307.38 (market cap $109.31B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Cloudflare Inc pays none. Which is the better fit depends on your goals.
| BMY | NET | |
|---|---|---|
Market Cap | $129.94B | $109.31B |
Sector | Health | Technology |
52-Week High | $65.89 | $310.40 |
52-Week Low | $42.60 | $160.16 |
Enterprise Value | $163.92B | $108.67B |
Dividend Yield | 3.96% | — |
Trailing returns across standard periods
Latest headlines on both assets
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →